Table 1.
Timepoint | Study period | |||||||
Enrolment | Allocation | Postallocation | ||||||
At arrival | After evaluation | During treatment | 24 hours after treatment | 7 days after treatment | Discharge | 30 days after treatment | 90 days after treatment | |
Enrolment | ||||||||
Eligibility screen | X | |||||||
Informed consent | X | |||||||
Allocation | X | |||||||
Interventions | ||||||||
GA | X | |||||||
CS | X | |||||||
Assessments | ||||||||
Baseline variables | X | X | ||||||
Brain image | X | X | ||||||
mRS | X | X | ||||||
NIHSS | X | X | X | X | X | |||
mTICI | X | |||||||
All-cause mortality | X | |||||||
Length of stay | X | |||||||
ICU stay and length | X | |||||||
Converting rate | X | |||||||
Adverse event | X | X |
CS, conscious sedation; GA, general anaesthesia; ICU, intensive care unit; mRS, modified Rankin Score; mTICI, modified Thrombolysis in Cerebral Infarction; NIHSS, National Institute of Health Stroke Scale.